Literature DB >> 23778649

Comparison of kidney function between donation after cardiac death and donation after brain death kidney transplantation.

Hani M Wadei1, Michael G Heckman, Bhupendra Rawal, C Burcin Taner, Waleed Farahat, Laila Nur, Martin L Mai, Mary Prendergast, Thomas A Gonwa.   

Abstract

BACKGROUND: Kidney graft survival is comparable between donation after cardiac death (DCD) and donation after brain death (DBD) kidney transplantation. However, data concerning kidney function after DCD kidney transplantation are lacking.
METHODS: We retrospectively compared kidney function between 64 DCD and 248 DBD kidney transplant recipients. Graft function was assessed using iothalamate glomerular filtration rate at 1, 4, and 12 months, then annually. The primary endpoint was the composite of death-censored graft loss or two consecutive iothalamate glomerular filtration rates less than 50 mL/min/1.73 m² occurring within 5 years from transplantation. Secondary endpoints included death and graft loss or death.
RESULTS: Of the 312 patients, 102 (33%) experienced the primary endpoint, 78 (25%) experienced graft loss or death, and 44 (14%) died. In multivariable Cox regression analysis, there was no difference between DCD and DBD recipients regarding the primary endpoint (relative risk [RR], 1.16; P=0.59), death (RR, 0.97; P=0.94), or graft loss or death (RR, 1.09; P=0.79). In the subgroup of 64 DCD recipients, each 10-year increase in donor age was associated with increased risk of the primary endpoint (RR, 1.51; P=0.027) with the highest risk observed for donors older than 45 years (RR, 4.81; P=0.001). Delayed graft function affected 45% of the DCD recipients but had no impact on kidney function, graft survival, or patient survival.
CONCLUSIONS: Posttransplantation kidney function is comparable between DCD and DBD kidney transplantations. In the subgroup of DCD recipients, kidneys from donors older than 45 years may be associated with a higher risk of poor kidney function; however, this finding requires validation in a larger patient group.

Entities:  

Mesh:

Year:  2013        PMID: 23778649     DOI: 10.1097/TP.0b013e31829807d1

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  19 in total

Review 1.  Kidney donation after circulatory death: current evidence and opportunities for pediatric recipients.

Authors:  Matko Marlais; Chris Callaghan; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2015-09-17       Impact factor: 3.714

2.  Effect of organ donation after circulatory determination of death on number of organ transplants from donors with neurologic determination of death.

Authors:  Vivek Rao; Sonny Dhanani; Janet MacLean; Clare Payne; Elizabeth Paltser; Atul Humar; Jeffrey Zaltzman
Journal:  CMAJ       Date:  2017-09-25       Impact factor: 8.262

3.  Delayed Graft Function Phenotypes and 12-Month Kidney Transplant Outcomes.

Authors:  Isaac E Hall; Peter P Reese; Mona D Doshi; Francis L Weng; Bernd Schröppel; William S Asch; Joseph Ficek; Heather Thiessen-Philbrook; Chirag R Parikh
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

4.  Survival Benefit of Donation After Circulatory Death Kidney Transplantation in Children Compared With Remaining on the Waiting List for a Kidney Donated After Brain Death.

Authors:  Sarah J Kizilbash; Michael D Evans; Blanche M Chavers
Journal:  Transplantation       Date:  2022-03-01       Impact factor: 5.385

Review 5.  Biomarkers for renal transplantation: where are we?

Authors:  Fangmin Ge; Qiaoding Dai; Weihua Gong
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-10-01

6.  Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol.

Authors:  J Moritz Kaths; Juan Echeverri; Nicolas Goldaracena; Kristine S Louis; Paul Yip; Rohan John; Istvan Mucsi; Anand Ghanekar; Darius Bagli; Markus Selzner; Lisa A Robinson
Journal:  J Vis Exp       Date:  2016-02-21       Impact factor: 1.355

7.  Fifteen-Year Analysis of Deceased Kidney Donation: A Single Transplant Center Experience in a Region of Northern Italy.

Authors:  Vania Cuna; Giorgia Comai; Maria Cappuccilli; Olga Baraldi; Irene Capelli; Matteo De Liberali; Lorenzo Gasperoni; Diletta Conte; Matteo Ravaioli; Antonio D Pinna; Gaetano La Manna
Journal:  Med Sci Monit       Date:  2017-09-18

8.  Kidney Transplants in Controlled Donation Following Circulatory Death, or Maastricht Type III Donors, With Abdominal Normothermic Regional Perfusion, Optimizing Functional Outcomes.

Authors:  Patricia Ramirez; David Vázquez; Gabriel Rodríguez; Juan José Rubio; Marina Pérez; Jose Maria Portolés; Joaquín Carballido
Journal:  Transplant Direct       Date:  2021-07-16

9.  α-Melanocyte stimulating hormone treatment in pigs does not improve early graft function in kidney transplants from brain dead donors.

Authors:  Willem G van Rijt; Niels Secher; Anna K Keller; Ulla Møldrup; Yahor Chynau; Rutger J Ploeg; Harry van Goor; Rikke Nørregaard; Henrik Birn; Jørgen Frøkiaer; Søren Nielsen; Henri G D Leuvenink; Bente Jespersen
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

Review 10.  Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation?

Authors:  T C Saat; E K van den Akker; J N M IJzermans; F J M F Dor; R W F de Bruin
Journal:  J Transl Med       Date:  2016-01-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.